investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer
Ian Tannock
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ian Tannock
Princess Margaret Cancer Centre
Toronto, Canada
Related projects
Norman Wolmark
NRG Oncology Network Group Operations Center
Prostate
Radiation Oncology
Surgery / Surgical oncology
Ian M Thompson
San Antonio Center for Biomarkers of Risk For Prostate Cancer (SABOR)
Prostate
Pathology
Janet E Dancey
NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network
Prostate
Susan Halabi
Validation of Prognostic and Pathway Signatures in Lethal Prostate Cancer
Prostate
Pathology
Andrew J Vickers
Dynamic, Multi-Cohort Prediction Modeling of Prostate Biopsy Outcome
Prostate
Pathology
Charles D Blanke
SWOG Network Group Operations Center of the NCTN
Prostate
Robert L Comis
ECOG-ACRIN Operations Center
Prostate
Frank B Hu
Harvard Transdisciplinary Research in Energetics and Cancer Center
Prostate
Stephen N Thibodeau
Prostate Cancer Susceptibility: The ICPCG Study
Prostate
Pathology